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Background/Aims: Endoscopic retrograde cholangiopan-
creatography (ERCP) is the standard approach for the man-
agement of biliary complications in liver transplant patients; 
however, its safety and efﬁ  cacy have not been established in 
this setting. This study was performed to evaluate the safety 
and long-term efﬁ  cacy of ERCP in transplant patients. Meth-
ods: The case reports of 1,500 liver transplant patients were 
reviewed. Orthotopic liver transplantation (OLT) patients were 
matched 1:2 with non-OLT patients and followed-up for long-
term outcome (median, 7.4 years). Results: Of the 1,500 
liver transplant patients, 94 (6.3%) underwent 150 ERCPs 
after OLT. Anastomotic strictures were present in 45 patients, 
biliary stones in 24, biliary leaks in 7, papillary stenosis in 
2, and primary sclerosing cholangitis in 1. An ERCP success 
rate of 90.7% was achieved; biliary stenting led to resolution 
of the bile leak in 7/7 (100%) patients, and biliary stones 
were removed in 21/24 (87.5%) patients. In addition, 34 of 
45 patients with anastomotic stricture underwent endoscop-
ic dilation. We obtained complete resolution in 22/34 (64.7%) 
patients. OLT patients did not show a higher probability of 
complications (odds ratio [OR], 1.04), of pancreatitis (OR, 
0.80) or of bleeding (OR, 1.34). Conclusions: ERCP is safe 
and effective for the treatment of post-OLT biliary complica-
tions, has a low rate of pancreatitis and results in a durable 
effect. (Gut Liver 2011;5:328-334)
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INTRODUCTION
Biliary complications are a major cause of morbidity and 
mortality following orthotopic liver transplantation (OLT), oc-
curring in 11% to 38% of OLT recipients.
1-3 Most common 
biliary complications after OLT are biliary leaks and strictures, 
choledocholithiasis, functional ampullary obstruction.
4-6 Usu-
ally, during OLT the biliary tract is reconstructed using a duct-
to-duct anastomosis, such as choledochocholedochostomy (CCS) 
or hepaticocholedochostomy, or, less frequently, by Roux-en-Y 
hepaticojejunostomy. The biliary drainage is the Achilles heel 
of OLT and biliary strictures occur in 4% to 13% of patients 
after OLT surgery.
1-3 These strictures are categorized as either 
anastomotic or nonanastomotic. Technical problems are the 
most frequent cause of anastomotic strictures (size mismatch 
between the donor and recipient ducts) which represent more 
than 80% of post-OLT biliary strictures.
7-9 Nonanastomotic bili-
ary strictures are mainly caused by ischemia due to hepatic 
artery thrombosis and prolonged graft cold ischemia time.
10 Less 
frequent causes of nonanastomotic biliary strictures are blood 
type incompatibility, chronic rejection, recurrent disease and 
cytomegalovirus infection.
11-13 
Despite the lack of large, prospective, randomized studies, 
endoscopic retrograde cholangiopancreatography (ERCP) is the 
preferred diagnostic and therapeutic procedure of choice in 
patients with duct-to-duct anastomosis; however, its long-term 
impact on morbidity and mortality rates has not been fully es-
tablished due to the relatively short follow-up. 
Moreover, low post-ERCP complication rates in OLT patients 
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infection have been reported in prior studies (2% to 6%)
14-25 
confirming the safety of such endoscopic procedure in this par-
ticular subset of patients; however, this conclusion was drawn 
without adequate control groups. The motivation for the present 
study also stems from a previous pilot study
26 where we found 
a lower rate of post-ERCP pancreatitis in our OLT recipients 
compared with the whole cohort of patients that underwent 
ERCP and a higher bleeding rate. Our study was planned with 
two main aims. First, to verify whether the discrepancy regard-
ing post-ERCP pancreatitis and bleeding rates was due to dif-
ferent indications and technical execution. To this purpose we 
compared the OLT population with a non-OLT control group of 
patients who underwent ERCP in our Institution, well matched 
for baseline demographic features, indications and technical ap-
proach.
Second, to address the issue of the long-term efficacy of 
ERCP in OLT patients with biliary complications we conducted 
a prolonged follow-up analysis on all OLT patients at our center 
with biliary complications who underwent ERCP. 
MATERIALS AND METHODS
1. OLT cohort deﬁ  nition
We retrospectively reviewed the medical, transplant clinic, 
endoscopy and radiology records of all adult recipients of OLT 
at the Liver Transplant Unit, Molinette Hospital, Torino, Italy, 
since October 1990 up to December 2007. The number of pa-
tients referred for ERCP and indication for the procedure was 
recorded. The indications for performing an ERCP were based 
on the history, radiological data, laboratory data, and histologic 
data showing a cholestatic pattern in the absence of cellular 
rejection. A liver biopsy was performed in all patients before 
ERCP. All ERCP procedures were performed by a pool of expe-
rienced biliary endoscopists (>2,500 career ERCPs with a work-
load of 360 ERCPs annually).
2. Control cohort deﬁ  nition 
Control subjects (n=188) were retrospectively identified 
among non-OLT patients who underwent ERCP, at the same 
hospital by the same endoscopists, matched 2:1 to OLT patients 
for age (±5 years), gender, date of ERCP (±12 months), indica-
tions, type of therapeutic intervention, and baseline risk factors 
for post-ERCP pancreatitis. In particular, patients with oncologic 
indications to ERCP were not considered; we included only pa-
tients with biliary stricture caused by surgical procedures (i.e., 
post-cholecystectomy complications). 
3. Complications and efﬁ  cacy of ERCP
The types of biliary complications diagnosed during ERCP and 
their managements were systematically retrieved from medical 
records both for OLT and non-OLT patients using a standardized 
form. Specific endoscopic therapies, success rate and the biliary 
outcomes were assessed. Endoscopic success for bile leaks was 
defined as the resolution of the leak on repeat cholangiography, 
solely utilizing endoscopic techniques and without the need for 
subsequent percutaneous or surgical procedures. Endoscopic 
success for biliary strictures was defined similarly as resolution 
of the source of obstruction on repeat cholangiography and/or 
improvement in cholestatic liver tests, solely using endoscopic 
procedures, and without the need for additional interventional 
radiology or surgical treatment. Partial resolution was defined 
by a requirement for only one subsequent therapeutic endo-
scopic intervention during follow-up.
Procedure-related complications were recorded; regarding 
post-ERCP pancreatitis, patients were classified as high risk if 
they had any of the high-risk parameters reported by Freeman 
and Guda.
27 Patients were classified as low risk if the primary 
indication of ERCP was biliary stone, stricture or bile leak. Pa-
tients with these biliary indications who were female, aged <60 
years or had pancreatic injection were still retained in the low-
risk category; however, we could not assess post-ERCP pancre-
atitis according to the difficulty of common bile duct cannula-
tion (number of attempts) or the unintentional pancreatic duct 
cannulation because not described in the endoscopy records. 
The definition of pancreatitis and grading of its severity were 
based on consensus criteria.
28 Post-ERCP pancreatitis was diag-
nosed when new-onset or increased abdominal pain caused a 
prolonged hospital stay of a planned admission of an inpatient 
and was associated with a serum amylase level increase at least 
3-fold above normal at approximately 18 hours after the proce-
dure. The severity was graded as “mild” for those patients with 
up to 3 additional hospital days, “moderate” for those staying 
between 4 to 10 days, and “severe” for those who spent more 
than 10 days or any of the following occurred: hemorrhagic 
pancreatitis, pancreatic necrosis, pancreatic pseudocyst or the 
need for percutaneous drainage or surgery. 
Bleeding was defined as clinical evidence of hemorrhage with 
a decrease in haemoglobin greater than 2 g/dL within 10 days 
from ERCP and the need for endoscopic or other method of ob-
taining hemostasis.
Cholangitis was diagnosed with the presence of fever, chills, 
elevated liver enzymes, and/or positive blood culture within 48 
hours after the procedure.
4. OLT cohort follow-up
All the patients were followed up with a standardized proto-
col. After OLT, the patients visited the outpatients clinics at our 
institutions every 1-6 months and were evaluated with blood 
examinations and abdominal ultrasonography; other imag-
ing modalities (i.e., computer tomography, magnetic resonance 
cholangio-pancreatography) or liver histologic assessment were 
requested if necessary. Follow-up data were obtained from the 
outpatient medical charts in May 2010. 
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post-ERCP complications rate between two different populations 
(OLT and non-OLT patients) with similar indications to ERCP, 
data about the long-term outcome of the non-OLT cohort were 
not considered. 
5. Statistical analysis
To compare the risk of ERCP related complications between 
OLT and non-OLT cohorts we used a conditional logistic regres-
sion model to allow a matched comparison within each strata 
of patients. In total 94 OLT patients and 188 non-OLT matched 
controls (1:2 ratio) were analyzed. A ratio higher than 1:2 was 
considered inefficient, because only little statistical power is 
gained by further increasing this ratio.
Estimates of the cumulative incidence of cause-specific death 
(liver disease-related, ERCP-related or other) were calculated for 
OLT subjects. Since the time of the event was observed incom-
pletely, due to left truncation where early deaths were missed, 
we applied the cumulative incidence method described by Meis-
ter and Schaefer,
29 combining corrections for left truncation and 
competing risks. 
RESULTS
During the period considered, 1,500 patients underwent 1,638 
OLTs at our institution with 1,353 (82.6%) undergoing a CCS; 
all patients who underwent ERCP had CCS. Of 1,353 patients 
with a CCS, 319 (23.6%) developed biliary complications and 94 
(29.5%) underwent ERCP; the remaining 225 patients (70.5%) 
had a surgical or percutaneous approach, due to surgeon’s deci-
sion (Fig. 1). Patients’ baseline demographic features and indica-
tions to ERCP are reported in Table 1.
In some cases (39 patients, 41.5%) more than one ERCP ses-
sion was needed, so the overall number of ERCP sessions was 
150. It was not possible to complete the diagnostic or therapeu-
Fig. 1. Flow chart of the OLT cohort. 
OLT, orthotopic liver transplantation; ERCP, endoscopic retrograde 
cholangiopancreatography. 
Table 1. Baseline Demographic Features and ERCP Characteristics of 










<30 3 (3.2) 8 (4.3)
31-40 10 (10.6) 15 (8.0)
41-50 20 (21.3) 42 (22.3)
51-60 49 (52.1) 92 (48.9)
>60 12 (12.8) 31 (16.5)
Years of ERCP*
1995-1996 12 (12.8) 24 (12.8)
1997-1998 9 (9.6) 18 (9.6)
1999-2000 13 (13.8) 21 (11.2)
2001-2002 17 (18.1) 38 (20.2)
2003-2004 12 (12.8) 25 (13.3)
2005-2006 7 (7.4) 13 (6.9)
2007-2008 24 (25.5) 49 (26.0)
OLT cause
Post hepatitis C cirrhosis 57 (60.6) -
Post hepatitis B cirrhosis 16 (17.0) -
Alcoholic cirrhosis 8 (8.5) -
Fulminant hepatitis 5 (5.3) -
Metabolic diseases 1 (1.1) -
Cryptogenic chirrosis 4 (4.3) -
Congenit biliary tract abnormality 1 (1.1) -
Re-OLT for primary non function 2 (2.1) -
Indication to ERCP*
Bile duct strictures 24 (25.5) 59 (31.4)
Bile leaks 7 (7.4) 12 (6.4)
Stones 24 (25.5) 51 (27.1)
Stones+strictures 17 (18.1) 29 (15.4)
Bile leaks+strictures 3 (3.2) 6 (3.2)
Migrated T-tubes+strictures 1 (1.1) -
Recurrent PSC 1 (1.1) 2 (1.1)
Papillary stenosis 2 (2.1) 4 (2.1)
Cholestasis 15 (16) 25 (13.5)
Sphincterotomy* 66 (70.2) 133 (70.7)
Data are presented as number (%).
ERCP, endoscopic retrograde cholangiopancreatography; OLT, ortho-
topic liver transplantation.
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tic session due to technical/anatomic difficulties with inability 
to obtain a deep biliary cannulation in 14/150 (9.3%) ERCPs.
Out of 94 patients, 15 (15.9%) showed no alteration of the 
biliary tract; the majority of them (8, 53.3%) were referred to 
ERCP for cholestasis without radiological abnormalities.
Patients with anastomotic strictures with or without con-
comitant bile leaks and/or stones (Table 1) were usually treated 
utilizing 1-5 ERCP procedures over a median of 12 weeks (range, 
0 to 18). Stricture was dilated with Boston-Microvasive balloon 
dilators in a sequential manner followed by stent placement. 
Every attempt was made to place increasing number of stents 
(up to a maximum of 3×10 Fr stents). At the beginning of the 
OLT experience at our institution, the policy was to manage 
the anastomotic biliary obstructions percutaneously or surgi-
cally; for this reason, only 34 of 45 (75%) patients with biliary 
strictures were treated endoscopically: 5 endoscopic sessions in 
3 patients, 4 in 4, 3 in 7, and 2 in 13 until the complete resolu-
tion of the stricture was obtained. Seven patients underwent 
only one endoscopic procedure. In 22 of 34 (64.7%) of these 
patients the ERCP was curative and no stenotic relapse was 
observed over the long term; a partial resolution was obtained 
in 6 patients (17.6%) but all of them needed surgery during 
the follow-up due to stricture recurrence. In the remaining 6 
patients without any endoscopic benefit, all 6 had duct-to-duct 
mismatches; they underwent radiological (percutaneous biliary 
dilation) or surgical procedures (hepaticojejunostomy). Technical 
factors (number of ERCPs performed, number of stents placed, 
balloon size, number of days stents in place) possibly associated 
with outcome were evaluated by univariate and multivariate 
analysis and no significant differences were found. The overall 
long-term outcome of OLT patients who underwent at least one 
endoscopic therapeutic session is reported in Table 2.
Most biliary leaks occurred at the T-tube site (7/10, 70%) and 
were treated with sphincterotomy and biliary stent placement. 
Biliary leak resolution was confirmed a median of 7 weeks 
(range, 4 to 12) after the initial ERCP during repeat cholangi-
ography: all patients were successfully treated endoscopically 
and none required percutaneous or surgical interventions; the 
remaining 3 were peri-anastomotic bile leaks with anastomotic 
biliary stricture which were treated by surgery as per decision of 
the surgical team. 
Among the patients with biliary stones, 21/24 (87.5%) were 
managed successfully with biliary sphincterotomy and endo-
scopic extraction of stones. Similarly, the two patients with pap-
illary stenosis were treated successfully with sphincterotomy.
The only patient with primary sclerosing cholangitis (PSC) 
recurrence was re-transplanted. 
Among non-OLT patients, 25/188 (13.2%) did not show any 
biliary alteration: all of them were referred to ERCP for unex-
plained cholestasis; 94/188 (50%) showed post-cholecystectomy 
biliary strictures with or without stones/bile leaks: ERCP was 
completely successful in 54 (57.4%) and partially successful in 
9 (9.5%). The remaining 29 patients were treated by radiological 
or surgical procedures. Of 67 patients with biliary stones, post-
surgery bile leaks or papillary stenosis, 56 (83.5%) obtained a 
complete resolution and 11 (16.5%) underwent surgery. Two pa-
tients with PSC had no benefit from the endoscopic procedure. 
1. Safety
Baseline demographic characteristics of OLT and non-OLT 
patients are reported in Table 1. OLT patients and non-OLT con-
trol patients are similar in matching variables, as expected for 
Table 2. Long-Term Outcome of Biliary Complications Treated by 
ERCP in OLT Patients
Patients treated with ERCP Baseline
Long-term resolution, 
No. (%)
Bile duct strictures 34 22 (64.7)
Bile leaks at T-tube site   7   7 (100.0)
Stones 24 21 (87.5)
Papillary stenosis   2   2 (100.0)
ERCP, endoscopic retrograde cholangiopancreatography; OLT, ortho-
topic liver transplantation.
Table 3. Comparison of ERCP Complications between OLT and Non-OLT Matched Patients by Conditional Logistic Regression
OLT patients (n=94) Non-OLT patients (n=188)
OR 95% CI p-value
No. (%) No. (%)
None 79 (84.0) 159 (84.6) 1 - -
Any complications 15 (16.0) 29 (15.4) 1.04 0.52-2.10 0.90
  Bleeding   8 (8.5) 13 (6.9) 1.34 0.50-3.57 0.55
  Pancreatitis   6 (6.4) 15 (8.0) 0.80 0.29-2.23 0.67
  Mild   3 (3.2) 7 (3.7) - - -
  Moderate   2 (2.1) 5 (2.7) - - -
  Severe   1 (1.1) 3 (1.6) - - -
Hyperpyrexia   1 (1.1) 1 (0.6) - - -
ERCP, endoscopic retrograde cholangiopancreatography; OLT, orthotopic liver transplantation; OR, odds ratio; CI, confidence interval.332  Gut and Liver, Vol. 5, No. 3, September 2011
successful matching, as shown in Table 1.
Table 3 reports the distribution of complications by group. 
The overall complications’ incidence is similar across groups 
(odds ratio [OR], 1.04; 95% confidence interval [CI], 0.52 to 2.10). 
Neither the hypothesis of an increased overall probability of 
post-ERCP bleeding (OR, 1.34; 95% CI, 0.50 to 3.57) nor the hy-
pothesis of a decreased probability of post-ERCP pancreatitis (OR, 
0.80; 95% CI, 0.29 to 2.23) for OLT vs non-OLT patients seems 
to be supported by study results. 
Post-ERCP bleeding was observed in 21 patients (7.4%) and 
occurred only in those who underwent sphincterotomy (199/282, 
70.5%). Fourteen bleeding episodes were seen during the proce-
dure and 7 were delayed (1 to 3 days after); all of them required 
epinephrine injection and/or haemoclip placement with a suc-
cessful outcome. 
Among OLT patients, none of them showed a cirrhotic relapse 
at the moment of papillotomy and coagulation parameters (INR 
and platelets count) were normal in all of them.
2. Follow-up
Of the 94 patients included in this study, none was lost to 
follow-up; 60 patients (63.8%) were still alive at May 2010 with 
a median follow-up from OLT of 9.9 years and from first ERCP 
of 7.4 years. Mortality was due to the recurrence of primary 
liver disease in 21/34 (61.7%), in 13/34 (38.3%) was due to oth-
er causes not related to post-OLT biliary complications: 5 had 
fatal cardiovascular diseases, 3 bacterial infections with sepsis, 
3 multiorgan failure, 2 de novo malignancies (Fig. 2). Interest-
ingly, none of the patients who underwent curative procedures 
(surgery, PTC, ERCP) for their initial biliary problems showed 
biliary complications again during the follow-up.
In particular none of the 22 patients with anastomotic stric-
ture who obtained a complete resolution by therapeutic ERCP 
showed a recurrence of the stricture over the long term.
DISCUSSION
Despite the lack of large, prospective, randomized stud-
ies, ERCP plays a primary role in the management of biliary 
complications after OLT. The success rates of ERCP reported by 
several retrospective studies
14-23 and two prospective studies
24,25 
support an endoscopic approach as the first line therapy of post-
OLT biliary complications. However, the vast majority of these 
studies report relatively short (12 to 54 months) follow-up peri-
ods; longer follow-up is crucial to ensure that success rates are 
durable and that successful endoscopic procedures have a long-
term impact on morbidity and mortality rates. 
Our data show that more than 90% of patients with post-OLT 
biliary stones or biliary leaks without biliary strictures are suc-
cessfully treated by ERCP. The endoscopic success rate is lower 
among patients with post-OLT biliary strictures (64.7%) but is 
similar to that previously reported by other studies.
19,21,30 What 
is new in this study is the evidence that the endoscopic efficacy 
is durable over the long-term (median follow up, 7.4 years) with 
no biliary recurrences throughout the follow-up. This observa-
tion is particularly interesting with regard to anastomotic stric-
tures: long-term failure did not occur in any patient. Similar 
data were obtained and reported by Morelli et al.
18 with smaller 
series (22 patients) and shorter follow-up (54 months); Grazia-
dei et al.
25 reported a long-term endoscopic success of 77% in 
65 patients with anastomotic strictures followed-up for 39.8 
months.
One main objective of our study was the evaluation of safety 
of ERCP in OLT patients; most of previous studies
14-25 reported 
low rates of ERCP-related complications (2% to 9%) despite the 
frequent use of potentially harmful interventions (papillotomy, 
biliary dilation, multiple stent insertion). In particular, the rate of 
post-ERCP pancreatitis was low with a nearly absent mortality; 
in a previous report,
26 we showed a significant lower percentage 
of post-ERCP pancreatitis among OLT patients compared with 
non-OLT patients. Moreover, of the 6 patients with pancreatitis 
only one had a severe outcome. This observation prompted us 
to design a careful matched cohort study in order to establish 
whether this discrepancy was simply due to baseline differences 
between the two populations or to an unrecognized protective 
factor in the transplanted group (i.e., immunosuppressive drugs). 
This hypothesis was not trivial as many anti-rejection drugs 
may inhibit the release of cytokines which are involved in the 
early local and late systemic inflammation during the onset of 
acute pancreatitis.
31-34 However, when compared with a well-
matched control group, post-ERCP pancreatitis risk among OLT 
patients was not significantly different both in quantity and in 
quality suggesting that biliary complications treated by ERCP 
represent a low risk for acute pancreatitis. Conversely, the ap-
parently higher rate of bleeding episodes found among OLT 
patients (26) was no longer confirmed when compared with the 
control group. 
Fig. 2. Cumulative incidences of primary liver disease-related death 
(solid line) and other causes of death (dashed line).
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Results of the long-term follow-up show that mortality was 
mainly due to the recurrence of primary liver disease and no 
one died for causes related to post-OLT biliary complications. 
Our data are similar to those reported by other Authors.
15,18,25 
Morelli and co-workers
18 reported no ERCP-related mortality, 
and Rizk et al.
15 and Graziadei et al.
25 showed that patient and 
graft survival did not differ significantly in the patients with 
anastomotic biliary strictures treated by ERCP compared with 
patients without strictures. 
Our study does have a potential methodological weakness: of 
45 patients with post-OLT biliary stricture shown by ERCP, only 
34 were endoscopically treated because our Liver Transplant 
Center has not always used therapeutic ERCP in the manage-
ment of biliary strictures after OLT, particularly in the early 
nineties. Despite evidence to the contrary,
3,35,36 many centers 
continue to manage the biliary complications percutaneously or 
surgically. However, age, sex, type of stricture and risk factors 
did not differ between the endoscopically treated group and the 
percutaneously/surgically treated group. 
In conclusion, therapeutic ERCP leads to long-term efficacy 
in the majority of OLT patients with biliary complications. 
Procedure-related adverse events are relatively uncommon and 
similar to those observed in a comparable group of non-OLT 
patients.
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